Stay updated on STX209 Effects in ASD Clinical Trial

Sign up to get notified when there's something new on the STX209 Effects in ASD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STX209 Effects in ASD Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:19:15.000Z thumbnail image
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the dose of STX209 being studied in a clinical trial for Autism Spectrum Disorder. This change may reflect a modification in the dosage being tested for its effects on MEG target parameters compared to baseline and placebo treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:15.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    22%
    Check dated 2024-05-22T21:04:24.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:39:43.000Z thumbnail image

Stay in the know with updates to STX209 Effects in ASD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STX209 Effects in ASD Clinical Trial page.